Markets:

Overview

News

Currencies

International

Treasuries

Xilio Therapeutics, Inc. - Common Stock (NQ:XLO)

8.300 -0.150 (-1.78%)

Streaming Delayed Price Updated: 11:02 AM EDT, Apr 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Xilio Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

XLO Stock Earnings: Xilio Therapeutics Misses EPS for Q2 2024 ↗

August 08, 2024

XLO stock results show that Xilio Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results

August 08, 2024

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors

June 13, 2024

From Xilio Therapeutics, Inc.

Via GlobeNewswire

XLO Stock Earnings: Xilio Therapeutics Misses EPS for Q1 2024 ↗

May 14, 2024

XLO stock results show that Xilio Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results

May 14, 2024

From Xilio Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 09, 2024

Via Benzinga

XLO Stock Earnings: Xilio Therapeutics Beats EPS for Q4 2023 ↗

April 01, 2024

XLO stock results show that Xilio Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results

April 01, 2024

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 01, 2024

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 01, 2024

Via Benzinga

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket ↗

April 01, 2024

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 01, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 01, 2024

It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 28, 2024

Via Benzinga

Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results ↗

March 28, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow traded up 0.06% to 39,785.29 while the NASDAQ fell 0.13% to 16,383.85. The...

Via Benzinga

Topics Stocks

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 28, 2024

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of...

Via Benzinga

Cancer Focused Micro-Cap Xilio Therapeutics Stock Doubles In One Session - Here's Why ↗

March 28, 2024

Xilio Therapeutics soars with exclusive license pact with Gilead Sciences to advance XTX301, a Phase 1 tumor-activated IL-12 program. $43.5 million upfront, $604 million potential payments, and tiered...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 28, 2024

Via Benzinga

Gold Gains 1%; Walgreens Narrows Earnings Forecast ↗

March 28, 2024

U.S. stocks traded slightly higher midway through trading, with the S&P 500 gaining around 0.1% on Thursday. The Dow traded up 0.06% to 39,785.87 while the NASDAQ rose 0.06% to 16,408.04. The S&P 500...

Via Benzinga

Topics Stocks

Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today? ↗

March 28, 2024

Biodexa Pharmaceuticals stock is up alongside heavy trading of BDRX after announcing positive news from a brain cancer treatment trial.

Via InvestorPlace

Why Is Xilio Therapeutics (XLO) Stock up 168% Today? ↗

March 28, 2024

Xilio Therapeutics stock is heading higher on Thursday with heavy trading of XLO shares after announcing a deal with Gilead.

Via InvestorPlace

US Stocks Flat; Initial Jobless Claims Fall To 210,000 ↗

March 28, 2024

U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday. Following the market opening Thursday, the Dow traded down 0.02% to 39,753.17 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 28, 2024

Via Benzinga

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing

March 28, 2024

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

March 28, 2024

From Gilead Sciences, Inc.

Via Business Wire

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

March 28, 2024

From Xilio Therapeutics, Inc.; Gilead Sciences, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 29, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.